FMED vs. SCHG
Compare and contrast key facts about Fidelity Disruptive Medicine ETF (FMED) and Schwab U.S. Large-Cap Growth ETF (SCHG).
FMED and SCHG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020. SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Total Return Index. It was launched on Dec 11, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FMED or SCHG.
Key characteristics
| FMED | SCHG | |
|---|---|---|
| YTD Return | 8.13% | 34.42% |
| 1Y Return | 27.92% | 44.81% |
| Sharpe Ratio | 1.87 | 2.64 |
| Sortino Ratio | 2.66 | 3.39 |
| Omega Ratio | 1.32 | 1.48 |
| Calmar Ratio | 1.48 | 3.61 |
| Martin Ratio | 8.21 | 14.40 |
| Ulcer Index | 3.58% | 3.10% |
| Daily Std Dev | 15.74% | 16.93% |
| Max Drawdown | -21.84% | -34.59% |
| Current Drawdown | -1.43% | -0.11% |
Correlation
The correlation between FMED and SCHG is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FMED vs. SCHG - Performance Comparison
In the year-to-date period, FMED achieves a 8.13% return, which is significantly lower than SCHG's 34.42% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FMED vs. SCHG - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is higher than SCHG's 0.04% expense ratio.
Risk-Adjusted Performance
FMED vs. SCHG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FMED vs. SCHG - Dividend Comparison
FMED has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.40%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.40% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% | 1.09% | 1.07% |
Drawdowns
FMED vs. SCHG - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum SCHG drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for FMED and SCHG. For additional features, visit the drawdowns tool.
Volatility
FMED vs. SCHG - Volatility Comparison
The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 3.49%, while Schwab U.S. Large-Cap Growth ETF (SCHG) has a volatility of 5.32%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.